Related Experiment Video

Updated: May 30, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Dose-related effect of statins in venous thrombosis risk reduction

Danai Khemasuwan1, Young Kwang Chae, Shikha Gupta

  • 1Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA 19141, USA. danai_md@hotmail.com

The American Journal of Medicine
|July 26, 2011
PubMed

Insights

Statin therapy and antiplatelet medications significantly reduce venous thromboembolism risk in atherosclerosis patients. Higher statin doses show a greater protective effect, with combined therapies offering the most benefit.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Atherosclerosis and venous thromboembolism share common inflammatory pathways.
  • The role of statin therapy in preventing venous thromboembolism is debated.
  • This study examines the impact of statins and antiplatelet agents on venous thromboembolism incidence in atherosclerosis patients.

Purpose of the Study:

  • To investigate the efficacy of statin therapy in reducing venous thromboembolism (VTE) occurrence.
  • To assess the impact of antiplatelet therapy on VTE in patients with atherosclerosis.
  • To determine if a dose-dependent relationship exists for statin use in VTE prevention.

Main Methods:

  • Retrospective cohort study of 1100 atherosclerosis patients (2005-2010).
  • Exclusion of patients on anticoagulation therapy.
  • Comparison of VTE incidence between statin users and non-users, and between different antiplatelet regimens.

Main Results:

  • Statin use was associated with a significantly lower VTE incidence (6.3% vs. 22.2%).
  • High-dose statins demonstrated a greater risk reduction compared to standard doses.
  • Dual antiplatelet therapy (aspirin and clopidogrel) and combined statin-antiplatelet therapy further decreased VTE occurrence.

Conclusions:

  • Statin therapy significantly reduces the risk of venous thromboembolism in atherosclerosis patients.
  • A dose-dependent relationship exists for statin efficacy in VTE prevention.
  • Combined use of statins and antiplatelet therapy provides maximal protection against VTE.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...